新药战略瞄准GLP-1药物,去年以来7款新药在美团首发

广州日报新花城
Sep 08

  据悉,GLP-1药物属于美团新药战略的一部分。从去年以来,已陆续有7款新药在美团首发,包括[美欧品]兴齐硫酸阿托品0.01%滴眼液、[诺和盈]司美格鲁肽、[诺和忻]司美格鲁肽、[穆峰达]替尔泊肽、[信尔美]玛仕度肽、[优乐思]多替诺雷,[达卫可]莱博雷生等,涵盖GLP-1、近视、痛风、抗失眠等领域。

  以莱博雷生为例,作为目前唯一可以通过线上平台购买的安眠药,价格不算低。部分用户对安眠药只有短期需求,对他们而言,购买一整盒并不划算。针对这些用户,美团提供拆零服务,并随药附赠小药盒和说明书,消费者可以用不超过100元的价格买到的抗失眠创新药莱博雷生。

  “美团还将在新药上继续发力,为用户提供新上市的好药,增强创新药可及性。”美团医药健康相关业务负责人表示。

(文章来源:广州日报新花城)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10